BCLSI

Bain Capital Life Sciences Investors Portfolio holdings

AUM $799M
1-Year Return 36.47%
This Quarter Return
-8.52%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$853M
AUM Growth
-$177M
Cap. Flow
+$30.3M
Cap. Flow %
3.56%
Top 10 Hldgs %
71.46%
Holding
37
New
3
Increased
4
Reduced
2
Closed
2

Top Buys

1
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
+$24.2M
2
PTGX icon
Protagonist Therapeutics
PTGX
+$17.9M
3
MRSN icon
Mersana Therapeutics
MRSN
+$9.89M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$8.46M
5
NRIX icon
Nurix Therapeutics
NRIX
+$6.82M

Top Sells

1
ARQT icon
Arcutis Biotherapeutics
ARQT
+$20.9M
2
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$15.6M
3
OMEG
Omega Alpha SPAC Class A Ordinary Shares
OMEG
+$3.93M
4
JYAC
Jiya Acquisition Corp. Class A Common Stock
JYAC
+$2.95M

Sector Composition

1 Healthcare 95.18%
2 Financials 3.66%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SYRS
26
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$6.03M 0.71%
626,442
– –
NAUT icon
27
Nautilus Biotechnolgy
NAUT
$89.3M
$5.38M 0.63%
2,000,000
– –
APTX
28
DELISTED
Aptinyx Inc. Common Stock
APTX
$4.96M 0.58%
8,891,758
– –
SLDB icon
29
Solid Biosciences
SLDB
$408M
$4.88M 0.57%
528,661
– –
PANA
30
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$4.88M 0.57%
500,000
– –
ARYE
31
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$4.86M 0.57%
500,000
– –
BLSA
32
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$4.83M 0.57%
487,500
– –
FLACU
33
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$2.96M 0.35%
300,000
– –
XFOR icon
34
X4 Pharmaceuticals
XFOR
$76.1M
$2.91M 0.34%
100,651
– –
SYRE icon
35
Spyre Therapeutics
SYRE
$977M
$2.7M 0.32%
213,908
+100,000
+88% +$1.26M
OMEG
36
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
– –
-400,000
Closed -$3.93M
JYAC
37
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
– –
-300,000
Closed -$2.95M
1
2